ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Dyslipidemia"

  • 2022 American Transplant Congress

    A Single-Center Cross-Sectional Analysis of Lipid Management in Kidney Transplant Recipients: Is It Time to Reassess KDIGO Guidelines?

    R. Saranu1, J. Pandav1, M. Balusu2, J. Azzi1, M. Y. Yeung1, M. McGrath1, E. Abdel-Basset1, S. Gabardi1, A. Chandraker1

    1Renal Division, Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA

    *Purpose: Cardiovascular disease remains the leading cause of mortality after kidney transplant, accounting for more than 30% of total deaths. Dyslipidemia is common following transplantation,…
  • 2022 American Transplant Congress

    Efficacy of a Multispecialty, Multidisciplinary Strategy to Improve the Level of Awareness and Control of Cardiovascular Risk Factors After Liver Transplantation

    G. Crespo, L. Sastre, R. García, C. Viñals, A. J. Amor, G. Yago, A. Hervas, L. Sánchez, J. Trabal, J. Molero, L. Escude, G. Pagano, M. Blasco, R. Gilabert, P. Ruiz, J. Colmenero, M. Navasa, E. Ortega

    Hospital Clinic, Barcelona, Spain

    *Purpose: Although liver transplant (LT) recipients are at high cardiovascular risk, the management of cardiovascular risk factors (CVRF) after LT is far from optimal. We…
  • 2022 American Transplant Congress

    Renal Transplantation and Statins Effects on Dyslipidemia in Renal Transplant Recipients

    Z. Arabi, A. Alghamdi, A. Alnasrullah, A. R. Altheaby, M. Tawhari, N. Alnazari

    KAMC, Riyadh, Saudi Arabia

    *Purpose: to review the effect of renal transplantation and adding of statins on dyslipidemia in renal transplant recipients.*Methods: A single center experience retrospective study of…
  • 2022 American Transplant Congress

    Efficacy and Safety of PCSK-9 Inhibitor, Evolocumab for Lipid Management in Kidney Transplant Recipients

    J. Pandav1, R. Saranu1, S. Muhsin1, N. Murakami1, S. Gabardi1, K. Safa2, A. Chandraker1

    1Renal division, Brigham and Women's Hospital, Boston, MA, 2Renal division, Massachusetts General Hospital, Boston, MA

    *Purpose: Dyslipidemia is common in kidney transplant recipients (KTRs). KDIGO guidelines suggest all KTRs should be treated with statins due to the high risk of…
  • 2022 American Transplant Congress

    Low-Dose Aspirin is More Critical Than Statins in Preventing Transplant Renal Artery Stenosis

    B. Ji, X. Tian, G. Jing, T. Yan, X. Wu, G. Cao, C. Zhang

    Urology, Henan Provincial People's Hospital, Zhengzhou, China

    *Purpose: To explore the clinical value of low-dose aspirin (100mg) and statins (10 ~ 20mg) in the prevention of transplant renal artery stenosis (TRAS).*Methods: A…
  • 2022 American Transplant Congress

    Evolution of Pretransplant Cardiac Risk Factor Burden and Major Adverse Cardiovascular Events in Liver Transplant Recipients Over Time

    C. Harrington, P. Levy, E. Cabrera, J. Gao, D. Gregory, C. Padilla, G. Crespo, L. VanWagner

    Northwestern Medicine, Chicago, IL

    *Purpose: The aim of this study is to evaluate the evolution of MACE and pre-LT cardiac risk factors in LTRs over time.*Methods: This is a…
  • 2021 American Transplant Congress

    Evaluation of Safety and Efficacy of PCSK9 Inhibitors in Solid Organ Transplant Recipients: Experience at a Large Multi-organ Transplant Center

    A. Ucci1, M. Norris2, J. Trofe-Clark2, T. Fallah2, M. Meck1, R. Samudralwar1, M. V. Genuardi3

    1Hospital of Univ of Pennsylvania, Philadelphia, PA, 2Penn Transplant Institute, Hospital of Univ of Pennsylvania, Philadelphia, PA, 3Cardiovascular Medicine Div, Hospital of Univ of Pennsylvania, Philadelphia, PA

    *Purpose: The aim of the study was to characterize the efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in solid organ transplant…
  • 2020 American Transplant Congress

    The Impact of Sirolimus on Weight Gain Post Heart Transplant

    S. M. Gore, C. E. Raphael, K. Mara, C. Arendt, A. L. Clavell, S. A. Bernard

    Mayo Clinic, Rochester, MN

    *Purpose: Obesity is common after heart transplant (HT), resulting in increased risk of new onset diabetes, all-cause and cardiovascular mortality and graft failure. Immunosuppressants (ISN)…
  • 2020 American Transplant Congress

    Selectively Transplanting Moderately to Severely Macrosteatotic Grafts: Does Recipient Metabolic Environment Affect Outcomes?

    P. J. Altshuler, A. Rios Diaz, O. Shaheen, A. P. Shah, W. R. Maley, A. Frank, C. Ramirez, J. Glorioso, H. Dang, A. S. Bodzin

    Department of Surgery, Thomas Jefferson University, Philadelphia, PA

    *Purpose: As incidence of Non-Alcoholic Steatohepatitis (NASH) cirrhosis rises, organ utilization remains stagnant. Recently, it has been shown that selective utilization of >30% macrosteatotic grafts…
  • 2020 American Transplant Congress

    Cardiovascular Improvement after Pancreatic Transplantation

    S. Y. Suen1, T. Sparkes1, R. Kalil2, B. Ravichandran1

    1Pharmacy, University of Maryland Medical Center, Baltimore, MD, 2Nephrology, University of Maryland Medical Center, Baltimore, MD

    *Purpose: Cardiovascular disease is a common cause of mortality in patients with uncontrolled diabetes. The purpose of this study is to assess whether patients receiving…
  • 1
  • 2
  • 3
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences